Gilead Sciences, Inc.Foster City, California, United States
Disclosure(s): Gilead Sciences, Inc.: Employee, Stocks/Bonds (Public Company)
154 - Pharmacokinetics and Safety of GS-1720 Following Multiple Ascending Doses in a Phase 1a Study in People Without HIV-1
Thursday, October 17, 20241:45 PM – 2:00 PM US PT